Illusione

Illusione Details OneOff Plans

The comeback of the OneOff brand is near. Illusione, which purchased the trademark to the brand last year, has announced the planned sizes and details….

Graded: The Ten Questions for 2017

Another year almost over, another Ten Questions to grade. As loyal readers of the site are aware, my colleague Charlie Minato wraps up each year…

Illusione Rothchildes CT

In the rush to get new cigars to market prior to U.S. Food & Drug Administration’s (FDA) Aug. 8, 2016 deadline for when they would…

Dion Giolito Purchases OneOff

Dion Giolito has purchased the rights to the OneOff cigars. The Illusione founder purchased the trademark from Cuban Crafters, which has owned the brand for…

Illusione, Cuban Stock Receive FDA Grandfather Status

Illusione and Cuban Stock have become the third and fourth premium cigar brands to receive approval as a grandfathered product by the U.S. Food &…

IPCPR 2017: Illusione

Illusione was on the list of companies that wasn’t supposed to have new products, and yet, Dion Giolito has two new cigars at the trade…

Illusione Launches New Website, Wholesale Sales Portal

Illusione has a new website with a bit of a trick up its sleeve. The company has launched a new website with an e-commerce portal for…

Illusione ULTRA Op No. 3

As has been mentioned numerous times before, Illusione released a plethora of cigars at the 2016 IPCPR Convention & Trade Show. Briefly, those releases are:…

Illusione Cigares Privé Corojo Prensado Suave

Compared to most years, the 2016 IPCPR Convention & Trade Show was quite different for Illusione, as the company celebrated its 10th anniversary by introducing multiple new…

Illusione Singularé 2016 Kadosh

Just before the 2016 IPCPR Convention and Trade Show, Illusione announced that it would be moving three of the previously released Singularé sizes into regular production,…

Illusione Rothchildes CT

Illusione doesn’t release new cigar lines every day, let alone every month. Yet in 2016, spurred by the rapidly approaching FDA regulation, Dion Giolito’s company…